Cargando…
Regulation, risk and safety of Faecal Microbiota Transplant
From its origins as a left-field, experimental, and even “maverick” intervention, faecal microbiota transplantation (FMT) is now a well-recognised, accepted, and potentially life-saving therapeutic strategy, for the management of recurrent Clostridiodes difficile infection (rCDI). It is being invest...
Autores principales: | Merrick, Blair, Allen, Liz, Masirah M Zain, Nur, Forbes, Ben, Shawcross, Debbie L., Goldenberg, Simon D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280140/ https://www.ncbi.nlm.nih.gov/pubmed/34316559 http://dx.doi.org/10.1016/j.infpip.2020.100069 |
Ejemplares similares
-
Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)—A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT)
por: Merrick, Blair, et al.
Publicado: (2023) -
Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial
por: Merrick, Blair, et al.
Publicado: (2020) -
The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
por: D. Goldenberg, Simon, et al.
Publicado: (2021) -
293. Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organism: a prospective, randomised placebo-controlled feasibility trial - The FERARO study (IRCTN reg. no. 34467677)
por: Merrick, Blair, et al.
Publicado: (2023) -
PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial
por: Woodhouse, Charlotte Alexandra, et al.
Publicado: (2019)